Clinical trial
A Phase 1 Study of Oral Debio 0123 in Combination With Carboplatin in Patients With Advanced Solid Tumors
NCT03968653 is registered in ClinicalTrials.gov with Debiopharm International SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of Oral Debio 0123 in Combination With Carboplatin in Patients With Advanced Solid Tumors
- Lead sponsor
- Debiopharm International SA
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- July 30, 2019
- Completion date
- October 23, 2025
- Enrollment
- 76 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid tumors